Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence
Singer, J. D., & Willett, J. B. (2003) · doi:10.1093/acprof:oso/9780195152968.001.0001 · Cited by 10,647
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 1×
“The increased discriminative value of presepsin for ICU and 90-day mortality was assessed using the category-free net reclassification improvement (cfNRI) and the integrated discrimination improvement (IDI) index [22].”
MethodSevere Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa040232 · Cited by 2,872 · cited 1×
“Shock at the time of randomization was defined as a score of 3 or 4 for the cardiovascular component of the Sequential Organ Failure Assessment (SOFA) score [19].”
MethodDecoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154 · cited 1×
“Recognition of pathogen-associated molecular patterns (PAMPs) from infecting microorganisms is mediated, within the innate immune system, by proteins of the Tolllike receptor (TLR) family [6].”
BackgroundKaukonen, K.-M., Bailey, M., Suzuki, S., Pilcher, D., & Bellomo, R. (2014) · JAMA · doi:10.1001/jama.2014.2637 · Cited by 1,459 · cited 1×
“Despite recent improvements, the incidence of sepsis in hospitalized patients increases steadily and mortality rates remain unacceptably high [1].”
BackgroundAlbumin Replacement in Patients with Severe Sepsis or Septic Shock
Caironi, P., Tognoni, G., Masson, S., Fumagalli, R., Pesenti, A., Romero, M., Fanizza, C., Caspani, L., Faenza, S., Grasselli, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305727 · Cited by 1,324 · cited 3×
“In the ALBIOS trial, patients were randomized to either albumin and crystalloids or crystalloids alone for volume replacement [17].”
BackgroundMethodInfluentialSelf-citationShozushima, T., Takahashi, G., Matsumoto, N., Kojika, M., Endo, S., & Okamura, Y. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-011-0254-x · Cited by 352 · cited 2×
“Presepsin is emerging as a novel circulating marker of sepsis [10–15].”
BackgroundEvaluation of a newly identified soluble CD14 subtype as a marker for sepsis
Yaegashi, Y., Sato, N., Suzuki, Y., Kojika, M., Imai, S., Takahashi, G., Miyata, M., Endo, S., Shirakawa, K., & Furusako, S. (2005) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0400-4 · Cited by 319 · cited 1×
“CD14 mediates the response to a variety of PAMPs [7] with the simultaneous release of a soluble fragment [25].”
BackgroundUsefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
Endo, S., Suzuki, Y., Takahashi, G., Shozushima, T., Ishikura, H., Murai, A., Nishida, T., Irie, Y., Miura, M., Iguchi, H., et al. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0435-2 · Cited by 311 · cited 1×
“Presepsin is emerging as a novel circulating marker of sepsis [10–15].”
BackgroundDiagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department
Liu, B., Chen, Y.-X., Yin, Q., Zhao, Y.-Z., & Li, C.-S. (2013) · Critical Care · doi:10.1186/cc13070 · Cited by 299 · cited 1×
“Presepsin is emerging as a novel circulating marker of sepsis [10–15].”
BackgroundUlla, M., Pizzolato, E., Lucchiari, M., Loiacono, M., Soardo, F., Forno, D., Morello, F., Lupia, E., Moiraghi, C., Mengozzi, G., et al. (2013) · Critical Care · doi:10.1186/cc12847 · Cited by 260 · cited 1×
“Presepsin is emerging as a novel circulating marker of sepsis [10–15].”
BackgroundVacca, P., Cantoni, C., Vitale, M., Prato, C., Canegallo, F., Fenoglio, D., Ragni, N., Moretta, L., & Mingari, M. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001749107 · Cited by 256 · cited 1×
“Interestingly, CD14 monocytes have been recently considered responsible for the development of immunosuppressive activity through the production of interferon-gamma in human umbilical cord matrix stem cells [26] or through the IL-1b/prostaglandin E2 axis during pregnancy [27].”
BackgroundMasson, S., Caironi, P., Spanuth, E., Thomae, R., Panigada, M., Sangiorgi, G., Fumagalli, R., Mauri, T., Isgrò, S., Fanizza, C., et al. (2014) · Critical Care · doi:10.1186/cc13183 · Cited by 240 · cited 1×
“In a preliminary study on a subgroup of 100 patients of the ALBIOS trial, we previously observed that presepsin had a better prognostic value than procalcitonin in patients with severe sepsis or septic shock [16].”
BackgroundSelf-citationCD14 and innate recognition of bacteria
Wright, S. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.1.6 · Cited by 218 · cited 4×
“CD14 mediates the response to a variety of PAMPs [7] with the simultaneous release of a soluble fragment [25].”
BackgroundInfluentialToll-like receptor co-receptors as master regulators of the immune response
Gioia, M. D., & Zanoni, I. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.05.008 · Cited by 127 · cited 1×
“CD14 is a broad-spectrum affinity component of the innate immunity and detects a variety of ligands associated also with Gram-positive bacteria, fungi, and viruses [7, 8].”
BackgroundSuberviola, B., Castellanos-Ortega, Á., Ruiz, A. R., López‐Hoyos, M., & Santibáñez, M. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3056-z · Cited by 121 · cited 1×
“In this context, circulating biomarkers may improve early recognition, optimal selection of appropriate therapies, and early risk stratification [3–5].”
BackgroundExpression of CD14 by Hepatocytes: Upregulation by Cytokines during Endotoxemia
Liu, S., Khemlani, L. S., Shapiro, R. A., Johnson, M. L., Liu, K., Geller, D. A., Watkins, S. C., Goyert, S. M., & Billiar, T. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5089-5098.1998 · Cited by 105 · cited 1×
“Acute inflammation may furthermore contribute to CD14 up-regulation by tissues other than monocytes [9].”
BackgroundThe Concept of Acute Kidney Injury and the RIFLE Criteria
Kellum, J. A., Bellomo, R., & Ronco, C. (2007) · Contributions to nephrology · doi:10.1159/000102010 · Cited by 94 · cited 1×
“Acute kidney injury was defined according to the risk, injury, failure, loss, and end-stage kidney injury (RIFLE) criteria [20], based on the daily incremental increases in serum creatinine from baseline.”
Ishikura, H., Nishida, T., Murai, A., Nakamura, Y., Irie, Y., Tanaka, J., & Umemura, T. (2014) · Critical Care · doi:10.1186/cc13700 · Cited by 82 · cited 1×
“Presepsin concentrations were higher in patients with lower blood platelets, suggesting a possible relationship between this marker and coagulation disorders [23].”
BackgroundPresepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis
Vodnik, T., Kaljević, G., Tadić, T., & Majkić‐Singh, N. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0061 · Cited by 82 · cited 1×
“Presepsin is emerging as a novel circulating marker of sepsis [10–15].”
BackgroundPresepsin (sCD14-ST) in emergency department: The need for adapted threshold values?
Chenevier‐Gobeaux, C., Trabattoni, E., Roelens, M., Borderie, D., & Claessens, Y.-É. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.09.019 · Cited by 74 · cited 1×
“Presepsin is emerging as a novel circulating marker of sepsis [10–15].”
BackgroundCD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells
Wang, D., Chen, K., Du, W. T., Han, Z., Ren, H., Chi, Y., Yang, S. G., Bayard, F., Zhu, D., & Han, Z. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.018 · Cited by 55 · cited 1×
“Interestingly, CD14 monocytes have been recently considered responsible for the development of immunosuppressive activity through the production of interferon-gamma in human umbilical cord matrix stem cells [26] or through the IL-1b/prostaglandin E2 axis during pregnancy [27].”
BackgroundSinger, M. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835f1b49 · Cited by 36 · cited 2×
“populations [3].”
Background
Cited by
Diagnosing sepsis – The role of laboratory medicine
Fan, S.-L., Miller, N. S., Lee, J., & Remick, D. G. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.07.002 · Cited by 173
“Neutrophil antigen expression: Many neutrophil antigens have been evaluated in the sepsis setting and some groups have studied soluble markers such as CD14 (57) and soluble CD16 (which is cleaved from the neutrophil cell surface after apoptosis).”
BackgroundStroeder, J., Bomberg, H., Wagenpfeil, S., Buecker, A., Schaefers, H.-J., Katoh, M., Groesdonk, H. V., & Minko, P. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003091 · Cited by 17
Metadata
- Authors
- Masson, S., Caironi, P., Fanizza, C., Thomae, R., Bernasconi, R., Noto, A., Oggioni, R., Pasetti, G. S., Romero, M., Tognoni, G., Latini, R., & Gattinoni, L.
- Venue
- Intensive Care Medicine
- Published
- 2014-10-16
- Volume
- 41
- Issue
- 1
- Pages
- 12-20
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2085565400
- Cited by
- 168
- References
- 27
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.